Skip to main content
The Patent Truth About Health, Innovation and Access
Heer Pardesi, who is 42 years old, holds her antiretroviral drugs for HIV. (Jonas Gratzer/LightRocket via Getty Images)

The Patent Truth About Health, Innovation and Access

Carol Adelman

View PDF

This report reviews and analyzes the following premises of the U.N.‘s High Level Panel on Access to Medicines, which are:

  1. Millions of poor people in low- and middle-income countries have been denied access to antiretroviral drugs and other medicines;
  2. Patents are the main cause of higher costs of medicines for poor people in low- and middle-income countries;
  3. The intellectual property system, including patents and voluntary licenses, limits research and disadvantages local producers in low- and middle- income countries.

These basic assumptions, drawing from the earlier Global Commission on HIV and the Law and the new High Level Panel on Access to Medicines, however, are not supported by global health research.

View PDF

Related Articles

How the U.S. Must Respond to China’s Exploitation of the COVID-19 Pandemic

Seth Cropsey & Harry Halem

On June 30, the Chinese Communist Party’s Standing Committee, the functional seat of power in mainland China, approved a “national security” law...

Continue Reading

Transcript: The Threat Posed by the Chinese Government and the Chinese Communist Party to the Economic and National Security of the United States

Walter Russell Mead & Christopher Wray

Following is the full transcript of the July 7th, 2020 Hudson online livestream event titled China’s Attempt to Influence U.S. Institutions: A Convers...

Continue Reading

Amidst Chinese Aggression, U.S. Cannot Afford to Dilute Its IP Laws

Adam Mossoff

America's trade war with China took an unexpected turn with the onset of the COVID-19 pandemic. As the global shutdown continues to ravage both countr...

Continue Reading